Primary completion date changed
Before: 30 Jun 2027. After: 30 Nov 2027.
Study sponsor: ADARx Pharmaceuticals, Inc. · ADRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 30 Jun 2027. After: 30 Nov 2027.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Efficacy of ADX-324 in preventing investigator-confirmed HAE attacks. After: Measure: Efficacy of ADX-324 in preventing HAE attacks.
Before: 31 Dec 2026. After: 30 Jun 2027.